ArticleInternational journal of molecular sciences2019

Evaluation of Protein Kinase Inhibitors with PLK4 Cross-Over Potential in a Pre-Clinical Model of Cancer.

Amreena Suri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.